| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/04/2010 | CA2733356A1 Influenza vaccines |
| 02/04/2010 | CA2732763A1 Methods for treating reperfusion injuries |
| 02/04/2010 | CA2732721A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | CA2732715A1 Treatment agent or preventative agent for osteoarthritis |
| 02/04/2010 | CA2732536A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 02/04/2010 | CA2732436A1 Vaccine against hpv |
| 02/04/2010 | CA2732003A1 Antibodies that neutralize botulinum neurotoxins |
| 02/03/2010 | EP2149604A1 Collections of repeat proteins comprising repeat modules |
| 02/03/2010 | EP2149585A1 Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 02/03/2010 | EP2149584A1 Method for enhancing immune response with peptide |
| 02/03/2010 | EP2149582A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
| 02/03/2010 | EP2149381A2 Method of treating malignancies through induction of blood immune responses |
| 02/03/2010 | EP2148699A1 Vaccination regimen for b-cell vaccines |
| 02/03/2010 | EP2148698A1 Microbial host-vector complementation system |
| 02/03/2010 | EP2148697A1 Lyophilised antigen composition |
| 02/03/2010 | EP2148694A2 Pharmaceutical agent for the treatment of fertility and gestation disorders, immunological diseases, and transplantation for use in veterinary medicine, particularly in horses, and methods for the production and treatment monitoring thereof |
| 02/03/2010 | EP1773876B1 Hpv vaccine comprising peptides from host cell proteins |
| 02/03/2010 | EP1301208B1 Mannose as intranasal vaccine adjuvant |
| 02/03/2010 | CN101641115A Epha3 antibodies for the treatment of solid tumors |
| 02/03/2010 | CN101638433A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 02/03/2010 | CN100586481C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/03/2010 | CN100586476C Therapeutic vaccine for Myostatin specific antibody and its preparation method |
| 02/03/2010 | CN100586475C Orally administered vaccine of hepatitis E and preparation process thereof |
| 02/02/2010 | US7657385 Structure-based hepatitis C virus drug design |
| 02/02/2010 | US7655784 transfer the sialic acids from a donor molecule (eg. oligosaccharides) to acceptor molecule (eg. oligo- and polysaccharides); foodstuffs or food additives |
| 02/02/2010 | US7655782 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 02/02/2010 | US7655757 Cytotoxic ribonuclease variants |
| 02/02/2010 | US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 02/02/2010 | US7655753 Conjugate |
| 02/02/2010 | US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655428 Immunoassay; sepsis, severe sepsis, septic shock and/or multiple organ dysfunction syndrome |
| 02/02/2010 | US7655427 Immunogenic proteins of Leptospira |
| 02/02/2010 | US7655426 Ephrin-B receptor protein involved in carcinoma |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655419 Methods and compositions for identifying anti-HCV agents |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | US7655398 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 02/02/2010 | US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/02/2010 | US7655248 Compositions and methods for treatment of candidiasis |
| 02/02/2010 | US7655247 Mixture comprising placental plasmodium polypeptide for use in treatment and prevention of parasitic infection of liver |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655245 Meningococcal serotype polypepties for use in diagnosis, prevention and treatment of microorganismal infection |
| 02/02/2010 | US7655244 In situ administering to nerve endings by injection or topical |
| 02/02/2010 | US7655243 Methods and systems for toxin delivery to the nasal cavity |
| 02/02/2010 | US7655242 Defensin-inducing agents |
| 02/02/2010 | US7655241 Methods and compositions for vaccination against or involving enterobacteriaceae bacteria |
| 02/02/2010 | US7655240 Cytotoxic necrotizing factor 1 (CNF1) which bears immunostimulatory properties towards the systemic and mucosal responses to orally administered ovalbumine, a prototype soluble protein antigen |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655238 Fusing to the antigen a Listerial truncated ActA protein; Listeria vaccine strains |
| 02/02/2010 | US7655237 obesity, metabolic syndrome, arteriosclerotic disease, arterial hypertension and functional ovaric hyperandrogenism |
| 02/02/2010 | US7655236 Lanthionine antibiotic compositions and methods |
| 02/02/2010 | US7655235 DNA vaccination which polynucleotides encode an HIV envelope protein; acquired immune deficiency syndrome (AIDS) |
| 02/02/2010 | US7655234 Inhibiting growth of a solid tumor cell that expresses the protein; cancer diagnosis |
| 02/02/2010 | US7655233 The solvent-detergent (S/D) process is used to inactivate enveloped viruses in plasma products; effectiveness of S/D treatment after fractionation and nanofiltration of an immune gamma globulin preparation |
| 02/02/2010 | US7655232 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
| 02/02/2010 | US7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID |
| 02/02/2010 | US7655230 Co-administration of a tissue plasminogen activator, anti-CD11b antibody and anti-CD18 antibody in stroke |
| 02/02/2010 | US7655229 Anti-FC-gamma RIIB receptor antibody and uses therefor |
| 02/02/2010 | US7655228 Ganglioside (GD3) specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | US7655227 Using a substance capable of inhibiting the binding between parathyroid hormone-related peptide (PTHrP) and a receptor; humanized anti-parathyroid hormone related protein 1-34 (anti-PTHrP (1-34)) antibody |
| 02/02/2010 | US7655218 Methods and compositions for detection and diagnosis of infectious diseases |
| 02/02/2010 | US7655216 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2459489C Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2428214C Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2366468C Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2239237C Chromatographic method for high yield purification and viral inactivation of antibodies |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2204277C Combined meningitis vaccine |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 02/01/2010 | CA2638190A1 Treatment of als |
| 01/28/2010 | WO2010012004A2 Monoclonal antibodies specific for pathological amyoid aggregates common to amyloids formed from proteins of differing sequence |
| 01/28/2010 | WO2010011999A2 Methods and compositions for eliciting an amyloid-selective immune response |
| 01/28/2010 | WO2010011893A1 Therapy targeting cancer stem cells |
| 01/28/2010 | WO2010011879A2 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | WO2010011870A2 Compositions and methods for the treatment of hepatitis c |
| 01/28/2010 | WO2010011697A1 Structural variants of antibodies for improved therapeutic characteristics |
| 01/28/2010 | WO2010011331A2 Compositions and methods related to sirt1 function |
| 01/28/2010 | WO2010011315A2 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | WO2010011161A1 Method for producing live cell vaccine for preventing mammary cancer |
| 01/28/2010 | WO2010010577A1 Constructing a dna chimera for vaccine development against leishmaniasis and tuberculosis |
| 01/28/2010 | WO2010010549A2 Methods of altering peripheral b cell populations and uses thereof |
| 01/28/2010 | WO2010010180A1 Novel compositions and methods |
| 01/28/2010 | WO2010010179A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010178A1 The tuberculosis rv2707c protein, compositions and uses thereof |
| 01/28/2010 | WO2010010177A1 Novel compositions and methods |
| 01/28/2010 | WO2010010055A1 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |